370 related articles for article (PubMed ID: 34217320)
1. Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma.
Xu Q; Xu H; Deng R; Wang Z; Li N; Qi Z; Zhao J; Huang W
Cancer Cell Int; 2021 Jul; 21(1):342. PubMed ID: 34217320
[TBL] [Abstract][Full Text] [Related]
2. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
Xu Q; Xu H; Chen S; Huang W
Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
[No Abstract] [Full Text] [Related]
3. Prognostic Role of ceRNA Network in Immune Infiltration of Hepatocellular Carcinoma.
Xu Q; Chen S; Hu Y; Huang W
Front Genet; 2021; 12():739975. PubMed ID: 34589117
[No Abstract] [Full Text] [Related]
4. Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma.
Xu Q; Hu Y; Chen S; Zhu Y; Li S; Shen F; Guo Y; Sun T; Chen X; Jiang J; Huang W
Front Mol Biosci; 2021; 8():683240. PubMed ID: 34124163
[No Abstract] [Full Text] [Related]
5. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
[TBL] [Abstract][Full Text] [Related]
6. Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
Kang K; Xie F; Mao J; Bai Y; Wang X
Front Oncol; 2020; 10():573141. PubMed ID: 33072607
[No Abstract] [Full Text] [Related]
7. Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma.
Xu Q; Chen S; Hu Y; Huang W
Cancer Cell Int; 2021 Oct; 21(1):582. PubMed ID: 34717651
[TBL] [Abstract][Full Text] [Related]
8. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
Zhang C; Li Z; Qi F; Hu X; Luo J
Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
[TBL] [Abstract][Full Text] [Related]
9. Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma.
Wang J; Ling S; Ni J; Wan Y
BMC Cancer; 2022 Jun; 22(1):638. PubMed ID: 35681134
[TBL] [Abstract][Full Text] [Related]
10. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer.
Zhou Z; Xie X; Wang X; Zhang X; Li W; Sun T; Cai Y; Wu J; Dang C; Zhang H
Front Genet; 2021; 12():623424. PubMed ID: 33664769
[TBL] [Abstract][Full Text] [Related]
11. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Bai Y; Lin H; Chen J; Wu Y; Yu S
Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
[No Abstract] [Full Text] [Related]
12. Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma.
Xu Q; Xu H; Deng R; Li N; Mu R; Qi Z; Shen Y; Wang Z; Wen J; Zhao J; Weng D; Huang W
Cancer Cell Int; 2021 Apr; 21(1):190. PubMed ID: 33794886
[TBL] [Abstract][Full Text] [Related]
13. Integrated Analysis of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma.
Zhao Y; Huang T; Huang P
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010268
[TBL] [Abstract][Full Text] [Related]
14. A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with
Fu J; Li Y; Li C; Tong Y; Li M; Cang S
Transl Cancer Res; 2021 Sep; 10(9):3963-3978. PubMed ID: 35116695
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.
Xie F; Bai Y; Yang X; Long J; Mao J; Lin J; Wang D; Song Y; Xun Z; Huang H; Yang X; Zhang L; Mao Y; Sang X; Zhao H
Int Immunopharmacol; 2020 Dec; 89(Pt A):107135. PubMed ID: 33189609
[TBL] [Abstract][Full Text] [Related]
16. Exploration of Key Genes Combining with Immune Infiltration Level and Tumor Mutational Burden in Hepatocellular Carcinoma.
Chen J; Zhang L; Lu CH; Xu CZ
Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38213141
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis.
Yan J; Wu X; Yu J; Zhu Y; Cang S
Front Oncol; 2020; 10():570654. PubMed ID: 33240814
[TBL] [Abstract][Full Text] [Related]
18. Gene expression and immune infiltration in melanoma patients with different mutation burden.
Wang L; Chen F; Liu R; Shi L; Zhao G; Yan Z
BMC Cancer; 2021 Apr; 21(1):379. PubMed ID: 33836680
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.
Zhou H; Chen L; Lei Y; Li T; Li H; Cheng X
Curr Probl Cancer; 2021 Apr; 45(2):100660. PubMed ID: 33012523
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification.
Bi Y; Jing Y; Guo L
Front Genet; 2022; 13():1017551. PubMed ID: 36263426
[No Abstract] [Full Text] [Related]
[Next] [New Search]